Compare Stocks: BIO.B, ILMN, MTD, and MEDP

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIO.B Bio-Rad Laboratories	$379.50	$366.93	$244.54 ▼ $379.50	$10.15B	1	38 shs	12 shs
ILMN Illumina	$226.54 -4.9%	$249.77	$112.65 ▼ $309.35	$34.25B	1.46	2.19 million shs	3.04 million shs
MEDP Medpace	$656.77 -1.0%	$621.39	$373.00 ▼ $693.97	$18.37B	1.12	329,380 shs	232,660 shs
MTD Mettler-Toledo International	$1,723.17 +1.5%	$1,512.80	$1,023.05 ▼ $1,737.99	$34.53B	1.16	183,168 shs	211,755 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIO.B Bio-Rad Laboratories	0.00%	0.00%	+3.95%	+12.61%	+25.19%
ILMN Illumina	+5.13%	-14.76%	-12.76%	+19.18%	+98.52%
MEDP Medpace	+2.37%	-1.53%	+10.68%	+12.89%	+11.69%
MTD Mettler-Toledo International	+0.93%	+0.56%	+14.02%	+19.44%	+20.47%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIO.B Bio-Rad Laboratories	$379.50	$366.93	$244.54 ▼ $379.50	$10.15B	1	38 shs	12 shs
ILMN Illumina	$226.54 -4.9%	$249.77	$112.65 ▼ $309.35	$34.25B	1.46	2.19 million shs	3.04 million shs
MEDP Medpace	$656.77 -1.0%	$621.39	$373.00 ▼ $693.97	$18.37B	1.12	329,380 shs	232,660 shs
MTD Mettler-Toledo International	$1,723.17 +1.5%	$1,512.80	$1,023.05 ▼ $1,737.99	$34.53B	1.16	183,168 shs	211,755 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIO.B Bio-Rad Laboratories	0.00%	0.00%	+3.95%	+12.61%	+25.19%
ILMN Illumina	+5.13%	-14.76%	-12.76%	+19.18%	+98.52%
MEDP Medpace	+2.37%	-1.53%	+10.68%	+12.89%	+11.69%
MTD Mettler-Toledo International	+0.93%	+0.56%	+14.02%	+19.44%	+20.47%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BIO.B Bio-Rad Laboratories	0.00	N/A	N/A	N/A
ILMN Illumina	2.37	Hold	$244.24	7.81% Upside
MEDP Medpace	2.23	Hold	$649.27	-1.14% Downside
MTD Mettler-Toledo International	2.33	Hold	$1,469.15	-14.74% Downside

Current Analyst Ratings Breakdown

Latest BIO.B, ILMN, MTD, and MEDP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
11/2/2026	ILMN Illumina	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C) ➝ Buy (B-)
11/2/2026	ILMN Illumina	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Sell	$113.00 ➝ $210.00
10/30/2026	ILMN Illumina	Evercore Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Underperform
10/30/2026	ILMN Illumina	JPMorgan Chase & Co. Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Overweight	$320.00 ➝ $300.00
10/26/2026	MEDP Medpace	BMO Capital Markets Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Market Perform	$600.00 ➝ $670.00
10/23/2026	ILMN Illumina	Stephens Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Overweight ➝ Equal Weight	$275.00
10/23/2026	MEDP Medpace	Truist Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Hold	$609.00 ➝ $633.00
10/23/2026	MEDP Medpace	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Neutral	$673.00 ➝ $700.00
10/23/2026	MEDP Medpace	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$730.00
10/23/2026	MEDP Medpace	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$699.00
10/23/2026	MEDP Medpace	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Equal Weight	$625.00 ➝ $675.00

(Data available from 11/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BIO.B Bio-Rad Laboratories	$2.58B	3.93	$10.02 per share	37.87	$276.16 per share	1.37
ILMN Illumina	$4.34B	7.89	$6.71 per share	33.74	$20.80 per share	10.89
MEDP Medpace	$2.53B	7.26	$17.24 per share	38.10	$20.91 per share	31.41
MTD Mettler-Toledo International	$4.03B	8.58	$50.97 per share	33.81	($1.16) per share	-1,485.49

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BIO.B Bio-Rad Laboratories	$759.90M	$8.25	46.00	N/A	N/A	8.59%	3.54%	2.48%	N/A
ILMN Illumina	$850M	$5.81	38.99	36.48	3.08	19.72%	28.38%	12.11%	N/A
MEDP Medpace	$451.12M	$18.04	36.41	33.63	2.51	18.24%	99.76%	24.47%	N/A
MTD Mettler-Toledo International	$869.19M	$44.43	38.78	32.90	3.38	21.91%	-1,212.14%	25.11%	11/5/2026 (Estimated)

Latest BIO.B, ILMN, MTD, and MEDP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2026	Q3 2026	MTD Mettler-Toledo International	$12.13	N/A	N/A	N/A	$1.07 billion	N/A
11/4/2026	Q3 2026	BIO.B Bio-Rad Laboratories	N/A	$2.65	N/A	$17.02	N/A	N/A
10/29/2026	Q3 2026	ILMN Illumina	$1.36	$1.62	+$0.26	$1.43	$1.15 billion	$1.17 billion
10/21/2026	Q3 2026	MEDP Medpace	$4.44	$4.84	+$0.40	$4.84	$714.47 million	$716.00 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BIO.B Bio-Rad Laboratories	N/A	N/A	N/A	N/A	N/A
ILMN Illumina	N/A	N/A	N/A	N/A	N/A
MEDP Medpace	N/A	N/A	N/A	N/A	N/A
MTD Mettler-Toledo International	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BIO.B Bio-Rad Laboratories	0.11	3.14	2.33
ILMN Illumina	0.57	2.63	2.05
MEDP Medpace	N/A	0.83	0.83
MTD Mettler-Toledo International	159.45	1.12	0.78

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BIO.B Bio-Rad Laboratories	0.01%
ILMN Illumina	89.42%
MEDP Medpace	77.98%
MTD Mettler-Toledo International	95.07%

Insider Ownership

Company	Insider Ownership
BIO.B Bio-Rad Laboratories	28.38%
ILMN Illumina	2.90%
MEDP Medpace	20.50%
MTD Mettler-Toledo International	0.71%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BIO.B Bio-Rad Laboratories	7,450	26.74 million	19.15 million	Not Optionable
ILMN Illumina	8,650	151.20 million	146.62 million	Optionable
MEDP Medpace	6,200	27.97 million	22.24 million	Optionable
MTD Mettler-Toledo International	18,100	20.04 million	19.90 million	Optionable

BIO.B, ILMN, MTD, and MEDP Headlines

Recent News About These Companies

Guidance Up, Trend Intact: Mettler-Toledo Is Today's Double-Confirmation Stock

1 hour ago | finance.yahoo.com

Mettler-Toledo International Inc. stock rises Wednesday, still underperforms market

1 hour ago | marketwatch.com

Mettler-Toledo International (NYSE:MTD) Sets New 52-Week High - Should You Buy?

November 4 at 10:59 AM | marketbeat.com

Sumitomo Mitsui Trust Group Inc. Sells 1,579 Shares of Mettler-Toledo International, Inc. $MTD

November 4 at 5:29 AM | marketbeat.com

AIA Group Ltd Purchases 6,037 Shares of Mettler-Toledo International, Inc. $MTD

November 4 at 3:03 AM | marketbeat.com

Mettler-Toledo's Q3 Earnings on Deck: What's in Store for the Stock?

November 3 at 5:23 PM | uk.finance.yahoo.com

Mettler-Toledo International, Inc. $MTD Shares Purchased by VIRGINIA RETIREMENT SYSTEMS ET Al

November 1 at 5:39 AM | marketbeat.com

Mettler-Toledo International Inc. to Present at Upcoming Investor Conferences

October 30, 2026 | businesswire.com

Mettler-Toledo International (MTD) Expected to Release Earnings on Thursday

October 29, 2026 | marketbeat.com

Citizens Financial Group Inc. RI Buys New Stake in Mettler-Toledo International, Inc. $MTD

October 29, 2026 | marketbeat.com

Mettler-Toledo International (NYSE:MTD) Sets New 12-Month High - What's Next?

October 28, 2026 | marketbeat.com

Mettler-Toledo International, Inc. (NYSE:MTD) Stock Rated "Hold" by Sell-Side Brokerages

October 27, 2026 | americanbankingnews.com

Mettler-Toledo International, Inc. (NYSE:MTD) Stock Has Consensus Price Target of $1,469.15 According to Brokerages

October 27, 2026 | marketbeat.com

What you need to know ahead of Mettler-Toledo’s earnings release

October 26, 2026 | msn.com

Mettler-Toledo International, Inc. $MTD Stock Position Lessened by Robeco Schweiz AG

October 25, 2026 | marketbeat.com

Robeco Institutional Asset Management B.V. Purchases 932 Shares of Mettler-Toledo International, Inc. $MTD

October 24, 2026 | marketbeat.com

Why Mettler-Toledo International (MTD) Is Drawing Fresh Attention

October 23, 2026 | finance.yahoo.com

Will Mettler-Toledo (MTD) Beat Estimates Again in Its Next Earnings Report?

October 22, 2026 | zacks.com

Canoe Financial LP Sells 4,750 Shares of Mettler-Toledo International, Inc. $MTD

October 22, 2026 | marketbeat.com

Mettler-Toledo International (NYSE:MTD) Reaches New 1-Year High - Here's Why

October 21, 2026 | marketbeat.com

1,459 Mettler-Toledo International, Inc. $MTD Shares Sold by TD Waterhouse Canada Inc.

October 21, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BIO.B, ILMN, MTD, and MEDP Company Descriptions

Bio-Rad Laboratories NYSE:BIO.B

$379.50 0.00 (0.00%)

As of 11/3/2026

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Illumina NASDAQ:ILMN

$226.54 -11.67 (-4.90%)

Closing price 04:00 PM Eastern

Extended Trading

$227.40 +0.87 (+0.38%)

As of 07:50 PM Eastern

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Medpace NASDAQ:MEDP

$656.77 -6.72 (-1.01%)

Closing price 04:00 PM Eastern

Extended Trading

$661.50 +4.73 (+0.72%)

As of 07:30 PM Eastern

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Mettler-Toledo International NYSE:MTD

$1,723.17 +25.13 (+1.48%)

Closing price 03:59 PM Eastern

Extended Trading

$1,720.92 -2.24 (-0.13%)

As of 07:46 PM Eastern

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BIO.B, ILMN, MTD, and MEDP Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BIO.B, ILMN, MTD, and MEDP Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BIO.B, ILMN, MTD, and MEDP Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BIO.B, ILMN, MTD, and MEDP Company Descriptions

Bio-Rad Laboratories NYSE:BIO.B

Illumina NASDAQ:ILMN

Medpace NASDAQ:MEDP

Mettler-Toledo International NYSE:MTD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BIO.B, ILMN, MTD, and MEDP Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BIO.B, ILMN, MTD, and MEDP Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BIO.B, ILMN, MTD, and MEDP Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BIO.B, ILMN, MTD, and MEDP Company Descriptions

Bio-Rad Laboratories NYSE:BIO.B

Illumina NASDAQ:ILMN

Medpace NASDAQ:MEDP

Mettler-Toledo International NYSE:MTD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools